Pathway for Diagnosing COPD



Similar documents
Prevention of Acute COPD exacerbations

COPD PROTOCOL CELLO. Leiden

COPD RESOURCE PACK SECTION 11. Fife Integrated COPD Care Pathways

PLAN OF ACTION FOR. Physician Name Signature License Date

COPD - Education for Patients and Carers Integrated Care Pathway

RES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP

Hospital to Physician Office to Home: A Respiratory Led Program Across the Continuum of Care

COPD Prescribing Guidelines

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)

National Learning Objectives for COPD Educators

Pulmonary Rehabilitation in Newark and Sherwood

COPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE

IN-HOME QUALITY IMPROVEMENT. BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK

Bronchodilators in COPD

Chronic obstructive pulmonary disease (COPD)

Understanding COPD. Carolinas Healthcare System

Chronic Obstructive Pulmonary Disease (COPD) Admission Order Set

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease

How To Test For A Lung Cancer

COPD. What is COPD? How many people have COPD in Canada? Who gets COPD?

Before prescribing for COPD management, the patient should have had appropriate assessment, including spirometry, as per NICE guidelines.

Southwark Clinical Commissioning Group Lambeth Clinical Commissioning Group

COPD and Asthma Differential Diagnosis

AECOPD: Management and Prevention

An Overview of Asthma - Diagnosis and Treatment

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Management of exacerbations in chronic obstructive pulmonary disease in Primary Care

Asthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

PTE Pediatric Asthma Metrics Reporting Updated January 2015

Objectives. Asthma Management

Global Initiative for Chronic Obstructive Lung Disease

Chronic Obstructive Pulmonary Disease

understanding the professional guidelines

COPD. (Chronic Obstructive Pulmonary Disease) (Emphysema) (Chronic Bronchitis) Education For Our Community

Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma

Pulmonary Rehabilitation: more than just an exercise prescription

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Exploratory data: COPD and blood eosinophils. David Price: am

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms

Insights for Improvement: Advancing COPD Care Through Quality Measurement. An NCQA Insights for Improvement Publication

Executive Summary... 4

Clinical Guideline. Recommendation 3: For stable COPD patients with respiratory symptoms

Clinical guideline Published: 23 June 2010 nice.org.uk/guidance/cg101

Wandsworth Respiratory Clinical Reference Group Annual Progress Report 2014/15

The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.

These factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:

April 2015 CALGARY ZONE CLINICAL REFERENCE PULMONARY CENTRAL ACCESS & TRIAGE

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Understanding COPD. An educational health series from

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease. A Canadian Thoracic Society clinical practice guideline (2011)

Breathing Easier In Tennessee: Employers Mitigate Health and Economic Costs of Chronic Obstructive Pulmonary Disease

Smoking Cessation Program

To provide standardized Supervised Exercise Programs across the province.

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

Sponsor Novartis Pharmaceuticals

30 DAY COPD READMISSIONS AND PULMONARY REHAB

Chronic Obstructive Pulmonary Disease Patient Guidebook

Chronic obstructive pulmonary disease: Management of adults with chronic obstructive pulmonary disease in primary and secondary care

Drug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS

Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway. Health Quality Ontario s integrated episode of care for COPD

COPD Intervention. Components:

Respiratory Care. A Life and Breath Career for You!

Pulmonary Rehabilitation. Steve Crogan RRT Pulmonary Rehabilitation, University of Washington Medical Center Seattle, Washington 10/13/07

2015 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

What we will discuss today

Breathe With Ease. Asthma Disease Management Program

NEWS NP S. Inside. Defining COPD. Is it COPD? National Prescribing Service Newsletter

Improvement in Dyspnea Implementing Pulmonary Rehabilitation in the Home

Success and Survival in Pulmonary Rehab

Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD

Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD)

David J. Lederer, MD, MS

3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy

Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey

HealthCare Partners of Nevada. Heart Failure

Idiopathic Pulmonary Fibrosis

Rehabilitation and Lung Cancer Resection. Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic

Respiratory Care Protocols

Pre-Operative Services Teaching Rounds 2 Jan 2011

Topic: New Treatment = Better Outcome?

How To Improve Health Care In South Essex

Logistics. Registration for free continuing education (CE) hours or certificate of attendance through TRAIN at:

FIBROGENIC DUST EXPOSURE

Pulmonary Associates of Richmond

Tests. Pulmonary Functions

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Standard of Care: Pulmonary Physical Therapy Management of the patient with pulmonary disease

Medicare Part A. Pulmonary Rehab Program Services Web-Based Training February 25, Q & As

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

RT AS PROJECT MANAGER:

The new Heart Failure pathway

The Respiratory Therapist As Disease Manager

Respiratory Concerns in Children with Down Syndrome

Medicines Use Review Supporting Information for Asthma Patients

Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD)

Best Practices in Managing Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Rehab Definitions Framework Self-Assessment Tool outpatient/ambulatory care Rehab Survey for Pulmonary Rehab

Transcription:

Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational risk factors No clinical features of asthma Tool #1 is different from Asthma Patient presents opportunistically to Physician Smoker/Ex-Smoker (> 10 pack years) 40 years old No clinical features of asthma Tool #1 is different from Asthma Have you used tobacco in the last 30 days? Tool #2 Quit Now 3 Questions Never smoked May still have if symptomatic but consider alternate diagnosis OR Ex-smoker 1. Congratulate! 2. Record pack years & quit date Tool #3 Calculating pack years Tool #4 Chart marker 3. Tool #5 Lung Health Questionnaire NO Non YES PATIENT AT RISK OF Smoker 1. Assess readiness to quit: Tool #2 Quit Now 3 Questions 2. Record pack years Tool #3 Calculating pack years Tool #4 Chart marker 3. Tool #5 Lung Health Questionnaire Ready to quit 1. Tool #6 QuitNow Referral Form 2. Tool #7 Kick the Butt patient pamphlet 3. Tool #8 Penticton Integrated Health Centre (PIHC) Nicotine Intervention referral form #802603

Non Investigation of Possible OPTIONAL Visit 2 Screening Consider trial of short acting bronchodilator Tool #9 Respiratory Inhaler Quick Reference Guide Tool #10 Package of inhaler device teaching sheets Screen with 6 Tool #11 6 Quick Start Guide Normal Abnormal Refer for Pre & Post Spirometry Tool #12 PF Lab Referral Form #809054 Consider 6 Annually Prn Smoker 1. Assess readiness to quit: Tool #2 Quit Now 3 Questions 2. Record pack years Tool #3 Calculating pack years Tool #4 Chart marker 3. Tool #5 Lung Health Questionnaire Not Ready To Quit Reassess next visit Offer help when ready Ready to quit 1. Tool #6 QuitNow Referral Form 2. Tool #7 Kick the Butt patient pamphlet 3. Tool #8 Penticton Integrated Health Centre (PIHC) Nicotine Intervention referral form #802603

Pathway for Diagnosing Visit 3 Confirmation Spirometry Results Normal result: Post Bronchodilator FEV1 > 80% FEV1/FVC > 0.7 + normal flow-volume loop Not Confirmed A normal result does not exclude the diagnosis of Asthma Tool #1 is different from Asthma Abnormal result: Post Bronchodilator FEV1/FVC < 0.7 Confirmed Exclude other potential diagnoses Arrange further investigations: Physical Examination, Detailed lung function, Chest X-Ray, Echocardiogram, Sputum, etc Follow Management Pathway Dr. Shannon Walker MD, FRCPC Patricia Rattee RRT, CRE Francis Hensen RN, BScN, M.Ed

Pathway for the Management of Suspected Investigation of Suspected Patient has confirmed Tool #13 Patient Care Flow Sheet Education Regarding Tool #14 Understanding Tool #15 Patient Education Resources MRC Level 3 Pulm Rehab: Tool #12 PF Lab Referral form If pt. unable to attend: Tool #18 Community Resp. Therapist Referral form Assessing Disability and Severity in Tool #16 Classification by Symptoms and Disability - MRC Dyspnea Scale Tool #17 Classification by Impairment of Lung Function MRC Level 2 Explore concerns Provide info re: Exercise, smoking and Self-management Canadian Thoracic Society Guidelines for Management Tool #19 CTS recommendations for management of - 2008 Update -highlights for primary care

Canadian Thoracic Society Guidelines for Management Tool #19 CTS recommendations for management of - 2008 Update -highlights for primary care Optimal Pharmacotherapy Tool #20 Optimal Pharmacotherapy Action Plan Tool #22 IH Flare-Up Action Plan Additional Interventions for Tool #21 Interventions for Annual Review by Physician Explore patients concerns Smoking cessation if appropriate Annual spirometry Review MRC scale & severity by spriometry Advise re: flu & pneumococcal vaccination Review patients pharmacological regime Check Inhaler Technique Review flare-up action plan Document exacerbation history Home oxygen assessment/abg if FEV1 < 50% or Oxygen saturation < 92% at rest on room air Assess for comorbidities Tool #23 Comorbidities Associated with Calculate BMI Annual Billing Code Tool # 42 Payment Description

Pathway for the Management of Acute Exacerbation of Patient has an acute exacerbation Increased dyspnea Increased cough and sputum Change in the colour of sputum for 24 hours or more Patient/family/caregiver starts Action Plan Contacts Physician for assessment appointment Tool #22 IH Exacerbation Flare-up Action Plan for antibiotics/prednisone use Factors to consider when determining whether to treat at home or in hospital: General condition Degree of breathlessness Ability to cope at home Level of consciousness Presence of cyanosis Worsening peripheral edema O2 saturation levels <92% on room air Go to ER or call 911 YES Concerning factors? NO Manage at home Patient admitted to in-patient care Condition deteriorates Monitoring by: Family Physician: Telephone F/U Tool #42 Payment Description Community Respiratory Therapist: Tool #18 Referral form #802604 Discharge after treatment to: Family Physician Community Respiratory Therapist Respirologist prn Go to Stable Management Pathway Condition improves

Start at step appropriate to symptoms Tool 9 Respiratory Inhaler Quick Reference Guide Mild Optimal Pharmacotherapy Step 1 SABA - Salbutamol 100 mcg 2 puffs QID prn with spacer and/or SAAC - Ipratropium Bromide 20 mcg 2-4 puffs QID with spacer Step 2 Tool #20 Mild Persistent Dyspnea LAAC - Tiotropium Bromide 18 mcg od + SABA Salbutamol prn or LABA - Salmeterol 50 mcg 1 puff BID or Formoterol 6 or 12 mcg BID + SABA Salbutamol prn Step 3 Moderate-Severe Infrequent AE LAAC Tiotropium Bromide 18 mcg od + SABA Salbutamol prn < 1/year or LABA Salmeterol 50 mcg BID or Formoterol 12 mcg BID + Salbutamol prn If Persistent Dyspnea LAAC Tiotropium + LABA Salmeterol or Formoterol + SABA Salbutamol prn If Persistent Dyspnea LAAC Tiotropium + ICS/LABA Advair 250/50 mcg BID or Symbicort 200/6 mcg 2 puffs BID + SABA Salbutamol prn Moderate-Severe Step 4 LAAC Tiotropium bromide 18 mcg OD Frequent AE + 1/year ICS/LABA Advair 500/50 mcg BID or Symbicort 200/6 mcg 2 puffs BID + SABA Salbutamol 100 mcg 2 puffs QID prn If Persistent Dyspnea Consider adding oral Theophylline OR Consider adding PD4 Inhibitor Derived from the 2008 Update CTS Guideline for Step 5 If still symptomatic and/or in addition to pharmacotherapy at any time Options include one or more of the following: Referral for Pulmonary Rehabilitation Tool #12 PF lab Referral Form 809054, if not already done Referral to Respirologist Tool #28 When to refer to a Respirologist - CTS Guidelines Referral for Home Oxygen Assessment Tool #12 PF Lab referral form 809054 Tool #34 Home Oxygen Program Subsidy Application Form 807800 Advanced Care Planning Tool #29 End of Life Care in CTS Guidelines Tool #30 GPAC Guidelines for Advanced Care Planning Tool #31 Comprehensive Approach to Management of Refractory Dyspnea in Advanced CTS Guidelines Tool #32 My Voice Patient Pamphlet Tool #33 Dr. Ann Gordon End of Life Video

REQUIRED Vaccinations Offer Annual Influenza Vaccine Offer Pneumococcal Vaccine Tool # 24 Vaccinations CTS Guidelines ADDITIONAL Annual Spirometry/Assess Oxygen Spirometry Tool #12 PF Lab Referral Form 809054 Home Oxygen Assessment if FEV1 < 50% Tool #12 PF Lab Referral Form 809054 Tool #34 Home Oxygen Program Subsidy Application Form Tool #21 Self Management/Education Education, collaborative goal setting, treatment plans Tool #25 Patient Self-Management Pamphlet Respirology Referral Tool #28 When to refer to a respirologist CTS Guidelines Exercise Advice If Patient MRC Scale Grade 2 Tool #26 Maintain an active lifestyle CTS Guidelines If Patient MRC Scale Grade 3 Pulmonary Rehabilitation Tool #12 PF Lab Referral Form 809054 Assessment of Disability & Severity Annual and prn assessment Tool #16 MRC dyspnea scale CTS guidelines Tool #17 Impairment of Lung Function CTS guidelines Interventions For Screen for Cardiovascular Risk Factors Primary and Secondary Prevention Calculate Body Mass Index (BMI) Tool #36 Body Mass Index Nomogram Screen For Osteoporosis Tool #35 Osteoporosis Risk Factors Action Plan Complete and Review Annually Tool #22 IH Flare-up Action Plan Identify & Manage Anxiety/Depression prn Tool #37 Patient Health Questionnaire (PHQ-9) Tool #38 Generalized Anxiety Disorder (GAD 7) Tool #39 Bounce Back Referral Form Tool #40 Bounce Back Patient Pamphlet Medications & Inhaler Technique Tool #9 Respiratory Inhaler Quick Reference Guide Tool #10 Package of Inhaler Device Teaching Sheets Screen for Obstructive Sleep Apnea (OSA) Tool #41 Epworth Sleepiness Scale Tool #12 'PF Lab Referral Form 809054' Smoking Cessation Tool #6 Quitnow.ca referral form Tool #7 Kick the Butt Patient Pamphlet Tool #8 PIHC Referral Form #802604 Advance Care Planning Tool #29 End of Life Care in Tool #30 GPAC Guidelines for Advanced Care Planning Tool #31 Dyspnea Management Guidelines Tool #32 My Voice Tool #33 Dr. Ann Gordon s End of Life Video